Open AccessRisk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma
Author(s) -
Daniele Santini,
Matteo Santoni,
Alessandro Conti,
Giuseppe Procopio,
Elena Verzoni,
Luca Galli,
Giuseppe Di Lorenzo,
Ugo De Giorgi,
Delia De Lisi,
Maurizio Nicodemo,
Marco Maruzzo,
Francesco Massari,
Sebastiano Buti,
Emanuela Altobelli,
Elisa Biasco,
Riccardo Ricotta,
Camillo Porta,
Bruno Vincenzi,
Rocco Papalia,
Paolo Marchetti,
Luciano Burattini,
Rossana Berardi,
Giovanni Muto,
Rodolfo Montironi,
Stefano Cascinu,
Giuseppe Tonini
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.8302
Subject(s) - medicine , general surgery
We retrospectively analyzed the risk of recurrence and conditional Disease-Free Survival (cDFS) in 63 patients with complete remission during treatment with tirosin kinase inhibitor (TKI), alone or with local treatment in metastatic renal cell carcinoma.